Liudmila Kulik Selected Research

Complement 3d Receptors (Complement Receptor 2)

5/2014	Deficiency of complement receptors CR2/CR1 in Cr2⁻/⁻ mice reduces the extent of secondary brain damage after closed head injury.
3/2009	Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liudmila Kulik Research Topics

Disease

6	Reperfusion Injury 01/2021 - 01/2007
6	Experimental Arthritis 01/2020 - 04/2006
5	Ischemia 01/2021 - 05/2009
5	Inflammation (Inflammations) 01/2020 - 05/2013
5	Arthritis (Polyarthritis) 01/2020 - 04/2006
3	Autoimmune Diseases (Autoimmune Disease) 02/2015 - 01/2007
2	Albuminuria 09/2015 - 02/2013
2	Gliosis 05/2014 - 04/2012
2	Choroidal Neovascularization 05/2013 - 05/2013
2	Rheumatoid Arthritis 04/2011 - 04/2006
1	Infections 01/2022
1	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2021
1	Immune System Diseases (Immune Disorders) 01/2021
1	Tuberculosis (Tuberculoses) 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Kidney Diseases (Kidney Disease) 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2018
1	Complement Factor H Deficiency 01/2018
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2017
1	Disease Progression 09/2015
1	Proteinuria 09/2015
1	Neuroinflammatory Diseases 05/2014
1	Brain Injuries (Brain Injury) 05/2014
1	Closed Head Injuries 05/2014
1	Craniocerebral Trauma (Head Injury) 05/2014
1	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2014
1	Delayed Graft Function 06/2013
1	Macular Degeneration (Age-Related Maculopathy) 05/2013
1	Brain Ischemia (Cerebral Ischemia) 02/2012
1	Infarction (Infarctions) 02/2012
1	Ischemic Stroke 02/2012
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2012
1	Synovitis 03/2007
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2007
1	Agammaglobulinemia (Hypogammaglobulinemia) 10/2002

Drug/Important Bio-Agent (IBA)

11	Complement System Proteins (Complement)IBA 10/2021 - 02/2012
11	Immunoglobulin M (IgM)IBA 10/2021 - 01/2007
8	AntibodiesIBA 01/2017 - 04/2006
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2006
5	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020 - 01/2007
4	Complement Receptors (Complement Receptor)IBA 01/2022 - 10/2002
4	AntigensIBA 01/2022 - 03/2007
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2013
2	CollagenIBA 01/2020 - 04/2011
2	Complement C3 (C3 Complement)IBA 01/2019 - 05/2014
2	EpitopesIBA 01/2018 - 05/2009
2	Immunoglobulin G (IgG)IBA 02/2015 - 06/2013
2	Complement 3d Receptors (Complement Receptor 2)IBA 05/2014 - 03/2009
2	Annexin A4IBA 02/2012 - 05/2009
2	AutoantibodiesIBA 04/2011 - 04/2006
2	Monoclonal AntibodiesIBA 01/2007 - 04/2006
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Capsid Proteins (Capsid Protein)IBA 01/2022
1	Viral ProteinsIBA 01/2022
1	complement C3d,gIBA 01/2021
1	Complement Inactivating AgentsIBA 01/2020
1	AerosolsIBA 01/2019
1	Complement Factor H (Factor H)IBA 01/2018
1	Collagen Type II (Type II Collagen)IBA 02/2015
1	Complement 3b ReceptorsIBA 02/2015
1	Complement C3-C5 Convertases (C3 Convertase)IBA 05/2014
1	Complement Factor B (Factor B)IBA 06/2013
1	salicylhydroxamic acid (SHAM)IBA 06/2013
1	Retinaldehyde (Retinal)IBA 05/2013
1	LigandsIBA 05/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2013
1	CytokinesIBA 04/2012
1	AmidesIBA 04/2011
1	N- alpha- benzoyl- N5- (2- chloro- 1- iminoethyl)- L- ornithine amideIBA 04/2011
1	Protein-Arginine DeiminasesIBA 04/2011
1	1,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)IBA 05/2009
1	Biological ProductsIBA 01/2007
1	AutoantigensIBA 01/2007
1	DNA (Deoxyribonucleic Acid)IBA 01/2007
1	Myosins (Myosin)IBA 01/2007
1	Interferon-alpha (Interferon Alfa)IBA 01/2007
1	Immunoglobulins (Immunoglobulin)IBA 01/2007
1	Fibrinogen (Factor I)FDA Link 04/2006

Therapy/Procedure

3	Therapeutics 01/2021 - 05/2013
1	Transplantation 03/2015
1	Immunomodulation 05/2014
1	Lasers (Laser) 05/2013